Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00731666 · ClinicalTrials.gov registry record · NA

Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)

A NA study of Erectile Dysfunction, sponsored by Coloplast A/S.

Completed
Registry status
NA
Development phase
40
Enrollment target
3
Study locations

NCT00731666: Completed NA study of Erectile Dysfunction, sponsored by Coloplast A/S.

NCT00731666 is a NA study of Erectile Dysfunction that has completed, run by Coloplast A/S. The registered enrollment target is 40 participants, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00731666, a NA study of Erectile Dysfunction, has completed, sponsored by Coloplast A/S.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
3
Study locations

Study Summary

This study is designed to assess the effectiveness of the Coloplast Titan® Inflatable Penile Prosthesis (IPP) at maintaining or increasing penile length after implantation of the device. It will incorporate a modified method of cylinder sizing during implantation and a max-inflate technique after implantation.

Conditions Studied

Erectile Dysfunction

Interventions

  • DEVICE Inflatable Penile Prosthesis

Study Locations (3)

Florida

  • James A Haley VA - Tampa

Louisiana

  • Regional Urology, LLC - Shreveport

Texas

  • University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2007-12
Est. Completion 2011-05
Phase NA
Coloplast A/S

21 total trials

What the finished NCT00731666 record still lists

NCT00731666 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Inflatable Penile Prosthesis is the first listed.

NCT00731666 reports a single indexed study location in Florida, Louisiana, Texas.

Frequently Asked Questions

What is clinical trial NCT00731666 about?

NCT00731666 is a clinical study titled "Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)". This study is designed to assess the effectiveness of the Coloplast Titan® Inflatable Penile Prosthesis (IPP) at maintaining or increasing penile length after implantation of the device. It will incorporate a modified method of cylinder sizing during implantation and a max-inflate technique after im...

What is the current status of trial NCT00731666?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-12. Estimated completion is 2011-05.

What conditions does trial NCT00731666 study?

This clinical trial studies the following conditions: Erectile Dysfunction.

What interventions are being tested in trial NCT00731666?

The interventions under investigation include: Inflatable Penile Prosthesis (DEVICE).

Who is sponsoring clinical trial NCT00731666?

This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00731666 being conducted?

This trial has 3 study locations across Florida, Louisiana, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00731666's enrollment target sits among peer trials

40 22nd of 33 higher than 11 of 33 other Erectile Dysfunction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00731666, the US trial registry maintained by the National Library of Medicine. NCT00731666 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.